Impact of video-led educational intervention on the uptake of influenza vaccine among adults aged 60 years and above in China: a study protocol for a randomized controlled trial

Abstract

Background Influenza is a global health threat to older adults, and the influenza vaccine is the most effective approach to prevent influenza infection. However, influenza vaccination coverage among Chinese older adults is far less than in developed countries such as the United States (4.0% vs. 64.9%). This study aims to increase influenza vaccination coverage in Chinese adults ≥60 years using a video-led educational intervention conducted by medical students. Methods A cluster randomized controlled trial will be conducted in 4 districts of Xi’an city, Shaanxi Province, China, using a stratified sampling approach. Adults aged ≥60 years will be recruited from 8 community hospitals. A self-administered questionnaire of knowledge, attitudes, and practices (KAP) will be employed to record the KAP score. During the 6-month interventional period, participants in the intervention group will receive educational videos focused on influenza and influenza vaccination, coupled with a group discussion conducted by the medical students. For those in the control group, no intervention will be provided. The outcomes measured in both groups will be the influenza vaccination coverage and the KAP scores of all participants. Discussion Medical students are more likely to educate older adults about scientific knowledge of influenza and its vaccine compared to clinical practitioners, who, most of the time, remain over-occupied due to the extensive workload. Video-led counseling and education could be a useful option to optimize older adults’ understanding of influenza and influenza vaccination. This eventually could improve the uptake of influenza vaccine among Chinese older adults. Trial registration Chinese Clinical Trial Registry; ChiCTR2000034330; Registered 3rd July 2019.

Effectiveness of a pay-it-forward intervention compared with user-paid vaccination to improve influenza vaccine uptake and community engagement among children and older adults in China: a quasi-experimental pragmatic trial

“…We evaluated the costs of the standard-of-care and pay-itforward interventions using a microcosting approach and reported costs in US$(2020). The costs of imple menting each group were estimated using invoices, onsite staff's self-reporting of the wages of health-care workers, and estimated opportunity costs (ie, the estimated total time spent on pay-it-forward-related activities) of community staff's time (appendix pp [13][14][15][16][17][18][19]. Additional costs in the pay-it-forward group related to volunteer time and the recruitment and donation processes.…”

“… 10 Community engagement is the process of working collaboratively with groups of people affiliated by proximity, interests, or situations with respect to issues affecting their wellbeing. 11 Despite a strong rationale for community engagement, 12 most programmes aiming to increase vaccination have used educational messages, 13 , 14 , 15 and none have engaged the public regarding influenza vaccinations. 16 , 17 Third, there is limited public funding to support influenza vaccination among high-risk populations.…”

COVID-19 Vaccine Hesitancy Among Older Adolescents and Young Adults: A National Cross-Sectional Study in China

“…Fortifying information regarding the importance, safety and efficacy of COVID-19 vaccines among older adolescents and young adults is a worthwhile endeavor. In this regard, online videos or applets from officials or professionals may be helpful ( 46 ) along with providing access to appropriate psychological interventions especially for older adolescents who exhibit vaccination hesitancy to vaccines ( 41 , 47 ). Such procedures may help dispel concerns about side effects of the COVID-19 vaccine.…”

Impact of video-led educational intervention on uptake of influenza vaccine among the elderly in western China: a community-based randomized controlled trial

“…We designed a community-based randomized controlled trial (RCT) to perform the present study, which was prospectively registered at the Chinese Clinical Trial Registry (ChiCTR2000034330) on 02/07/2020. A detailed research protocol was reported elsewhere previously [ 22 ]. In short, we selected Xi’an, the capital city of Shaanxi province, as the representative region of western China.…”